BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20421844)

  • 21. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.
    Kalko SG; Paco S; Jou C; Rodríguez MA; Meznaric M; Rogac M; Jekovec-Vrhovsek M; Sciacco M; Moggio M; Fagiolari G; De Paepe B; De Meirleir L; Ferrer I; Roig-Quilis M; Munell F; Montoya J; López-Gallardo E; Ruiz-Pesini E; Artuch R; Montero R; Torner F; Nascimento A; Ortez C; Colomer J; Jimenez-Mallebrera C
    BMC Genomics; 2014 Feb; 15():91. PubMed ID: 24484525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depletion of the other genome-mitochondrial DNA depletion syndromes in humans.
    Elpeleg O; Mandel H; Saada A
    J Mol Med (Berl); 2002 Jul; 80(7):389-96. PubMed ID: 12110944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deoxynucleoside salvage enzymes and tissue specific mitochondrial DNA depletion.
    Wang L
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):370-81. PubMed ID: 20544522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective muscle fiber loss and molecular compensation in mitochondrial myopathy due to TK2 deficiency.
    Vilà MR; Villarroya J; García-Arumí E; Castellote A; Meseguer A; Hirano M; Roig M
    J Neurol Sci; 2008 Apr; 267(1-2):137-41. PubMed ID: 18021809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial DNA deletion mutations in patients with neuropsychiatric symptoms.
    Kato M; Nakamura M; Ichiba M; Tomiyasu A; Shimo H; Higuchi I; Ueno S; Sano A
    Neurosci Res; 2011 Apr; 69(4):331-6. PubMed ID: 21185889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA.
    Mancuso M; Salviati L; Sacconi S; Otaegui D; Camaño P; Marina A; Bacman S; Moraes CT; Carlo JR; Garcia M; Garcia-Alvarez M; Monzon L; Naini AB; Hirano M; Bonilla E; Taratuto AL; DiMauro S; Vu TH
    Neurology; 2002 Oct; 59(8):1197-202. PubMed ID: 12391347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel mutations in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy.
    Blakely E; He L; Gardner JL; Hudson G; Walter J; Hughes I; Turnbull DM; Taylor RW
    Neuromuscul Disord; 2008 Jul; 18(7):557-60. PubMed ID: 18508266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymidine kinase 2 enzyme kinetics elucidate the mechanism of thymidine-induced mitochondrial DNA depletion.
    Sun R; Wang L
    Biochemistry; 2014 Oct; 53(39):6142-50. PubMed ID: 25215937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset mitochondrial myopathy with dystrophic changes due to a G7497A mutation in the mitochondrial tRNA(Ser(UCN)) gene.
    Müller T; Deschauer M; Neudecker S; Zierz S
    Acta Neuropathol; 2005 Oct; 110(4):426-30. PubMed ID: 16133542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and muscle pathology in myopathic mitochondrial DNA depletion.
    Nevo Y; Soffer D; Kutai M; Zelnik N; Saada A; Jossiphov J; Messer G; Shaag A; Shahar E; Harel S; Elpeleg O
    J Child Neurol; 2002 Jul; 17(7):499-504. PubMed ID: 12269728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies.
    Filosto M; Mancuso M; Vives-Bauza C; Vilà MR; Shanske S; Hirano M; Andreu AL; DiMauro S
    Ann Neurol; 2003 Oct; 54(4):524-6. PubMed ID: 14520667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA.
    Mandel H; Szargel R; Labay V; Elpeleg O; Saada A; Shalata A; Anbinder Y; Berkowitz D; Hartman C; Barak M; Eriksson S; Cohen N
    Nat Genet; 2001 Nov; 29(3):337-41. PubMed ID: 11687800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression deregulation in postnatal skeletal muscle of TK2 deficient mice reveals a lower pool of proliferating myogenic progenitor cells.
    Paredes JA; Zhou X; Höglund S; Karlsson A
    PLoS One; 2013; 8(1):e53698. PubMed ID: 23341978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice.
    Zhou X; Solaroli N; Bjerke M; Stewart JB; Rozell B; Johansson M; Karlsson A
    Hum Mol Genet; 2008 Aug; 17(15):2329-35. PubMed ID: 18434326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different tissue distribution of a mitochondrial DNA duplication and the corresponding deletion in a patient with a mild mitochondrial encephalomyopathy: deletion in muscle, duplication in blood.
    Houshmand M; Gardner A; Hällström T; Müntzing K; Oldfors A; Holme E
    Neuromuscul Disord; 2004 Mar; 14(3):195-201. PubMed ID: 15036329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue specific distribution of pyrimidine deoxynucleoside salvage enzymes shed light on the mechanism of mitochondrial DNA depletion.
    Wang L; Eriksson S
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):400-3. PubMed ID: 20544526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions.
    Di Fonzo A; Bordoni A; Crimi M; Sara G; Del Bo R; Bresolin N; Comi GP
    Hum Mutat; 2003 Dec; 22(6):498-9. PubMed ID: 14635118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy.
    Wang L; Saada A; Eriksson S
    J Biol Chem; 2003 Feb; 278(9):6963-8. PubMed ID: 12493767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered gene transcription profiles in fibroblasts harboring either TK2 or DGUOK mutations indicate compensatory mechanisms.
    Villarroya J; de Bolós C; Meseguer A; Hirano M; Vilà MR
    Exp Cell Res; 2009 May; 315(8):1429-38. PubMed ID: 19265691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients.
    Navarro-Sastre A; Tort F; Garcia-Villoria J; Pons MR; Nascimento A; Colomer J; Campistol J; Yoldi ME; López-Gallardo E; Montoya J; Unceta M; Martinez MJ; Briones P; Ribes A
    Mol Genet Metab; 2012 Nov; 107(3):409-15. PubMed ID: 22980518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.